Literature DB >> 34150142

Effect of left or right gastric artery interventional embolization on obesity and ghrelin/leptin expression in pigs.

Hui Liu1, Xiangying Li2, Rihui Chen1, Dingcheng Liu1, Chao Tong1.   

Abstract

OBJECTIVE: To investigate the effect of left or right gastric artery interventional embolization on obesity and ghrelin/leptin expression in pigs.
METHODS: Thirty-two female Wuzhishan pigs aged 3-4 months were randomly divided into four groups, with eight pigs in each group: obesity + left gastric artery embolization group, obesity + right gastric artery embolization group, obesity + sham surgery group and healthy control group. The body weight and serum levels of ghrelin, leptin, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) before the operation, one month and three months after the operation, and the gastric pathology three months after the operation were compared.
RESULTS: The preoperative body weight, ghrelin level, leptin level, IL-6 level and TNF-α level of the obesity + sham surgery group, obesity + left gastric artery embolization group and obesity + right gastric artery embolization group were higher than those of the healthy control group (all P<0.05). One month after the operation, the body weight, ghrelin level, leptin level, IL-6 level and TNF-α level of the obesity + sham surgery group, obesity + left gastric artery embolization group and obesity + right gastric artery embolization group were higher than those of the healthy control group. The body weight, ghrelin level, IL-6 level and TNF-α level of the obesity + sham surgery group were higher than those of the obesity + left artery embolization group and obesity + right gastric artery embolization group (all P<0.05). Three months after the operation, the body weight, ghrelin level, leptin level, IL-6 level and TNF-α level of the obesity + sham surgery group were higher than those of the obesity + left artery embolization group, obesity + right artery embolization group and the healthy control group (all P<0.05).
CONCLUSION: Left or right gastric artery interventional embolization in pigs can effectively reduce body weight, which may be related to the reduced secretion of ghrelin, leptin and inflammatory factors. However, the clinical application and safety of left or right gastric artery embolization still need further study. AJTR
Copyright © 2021.

Entities:  

Keywords:  Gastric artery embolization; ghrelin/leptin; inflammatory factors; intervention; obesity; pigs

Year:  2021        PMID: 34150142      PMCID: PMC8205808     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  23 in total

1.  Surgical treatment of obesity--weighing the facts.

Authors:  Malcolm K Robinson
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

2.  Effect of Integrated Behavioral Weight Loss Treatment and Problem-Solving Therapy on Body Mass Index and Depressive Symptoms Among Patients With Obesity and Depression: The RAINBOW Randomized Clinical Trial.

Authors:  Jun Ma; Lisa Goldman Rosas; Nan Lv; Lan Xiao; Mark B Snowden; Elizabeth M Venditti; Megan A Lewis; Jeremy D Goldhaber-Fiebert; Philip W Lavori
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

3.  Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico.

Authors:  Carlos Adrián Alarcón Rojas; María Teresa Alvarez-Bañuelos; Jaime Morales-Romero; Héctor Suárez-Díaz; Juan Carlos Hernández-Fonseca; Guillermo Contreras-Alarcón
Journal:  Clin Breast Cancer       Date:  2018-08-22       Impact factor: 3.225

4.  Ghrelin suppression and fat loss after left gastric artery embolization in canine model.

Authors:  Dilmurat Bawudun; Yan Xing; Wen-Ya Liu; Yu-Jie Huang; Wei-Xin Ren; Mei Ma; Xiao-Dong Xu; Gao-Jun Teng
Journal:  Cardiovasc Intervent Radiol       Date:  2012-02-25       Impact factor: 2.740

5.  Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.

Authors:  Patrick M O'Neil; Andreas L Birkenfeld; Barbara McGowan; Ofri Mosenzon; Sue D Pedersen; Sean Wharton; Charlotte Giwercman Carson; Cecilie Heerdegen Jepsen; Maria Kabisch; John P H Wilding
Journal:  Lancet       Date:  2018-08-16       Impact factor: 79.321

6.  Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN): Six-Month Preliminary Data.

Authors:  Mubin I Syed; Kamal Morar; Azim Shaikh; Paul Craig; Omar Khan; Sumeet Patel; Hooman Khabiri
Journal:  J Vasc Interv Radiol       Date:  2016-08-24       Impact factor: 3.464

Review 7.  Gut hormones and appetite control.

Authors:  A M Wren; S R Bloom
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

Review 8.  Bariatric Left Gastric Artery Embolization for the Treatment of Obesity: A Review of Gut Hormone Involvement in Energy Homeostasis.

Authors:  Kevin Anton; Tariq Rahman; Ashok Bhanushali; Aalpen A Patel
Journal:  AJR Am J Roentgenol       Date:  2016-01       Impact factor: 3.959

9.  Stromal-vascular fraction content and adipose stem cell behavior are altered in morbid obese and post bariatric surgery ex-obese women.

Authors:  Karina R Silva; Sally Liechocki; João R Carneiro; Cesar Claudio-da-Silva; Clarissa M Maya-Monteiro; Radovan Borojevic; Leandra S Baptista
Journal:  Stem Cell Res Ther       Date:  2015-04-14       Impact factor: 6.832

10.  Obesity promotes the expansion of metastasis-initiating cells in breast cancer.

Authors:  Mélanie Bousquenaud; Flavia Fico; Giovanni Solinas; Curzio Rüegg; Albert Santamaria-Martínez
Journal:  Breast Cancer Res       Date:  2018-09-04       Impact factor: 6.466

View more
  1 in total

Review 1.  Weight Loss and Gastrointestinal Hormone Variation Caused by Gastric Artery Embolization: An Updated Analysis Study.

Authors:  Yi Tang; Xiaohui Pan; Ge Peng; Nanwei Tong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-16       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.